|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
|
CA2115140A1
(en)
|
1991-08-07 |
1993-02-18 |
Lola M. Reid |
Proliferation of hepatocyte precursors
|
|
CA2177043C
(en)
*
|
1993-11-19 |
2011-08-09 |
Lola C.M. Reid |
Hepatoblasts and method of isolating same
|
|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
|
WO1996020456A1
(en)
*
|
1994-12-23 |
1996-07-04 |
International Remote Imaging Systems, Inc. |
Method and apparatus of analyzing particles in a fluid sample and displaying same
|
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
US6043092A
(en)
|
1996-03-18 |
2000-03-28 |
University Of Pittsburgh |
Cell culture media for mammalian cells
|
|
WO1999031222A1
(en)
*
|
1997-12-18 |
1999-06-24 |
Willem Frederik Van Eelen |
Industrial scale production of meat from in vitro cell cultures
|
|
EP1064353B1
(de)
|
1998-03-18 |
2002-11-06 |
Massachusetts Institute Of Technology |
Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane
|
|
EP2308996A1
(de)
|
1998-03-30 |
2011-04-13 |
NorthWest Biotherapeutics, Inc. |
Therapeutische und diagnostische Anwendungen auf Grundlage der Wirkung der CXCR-4 und SDF-1 Gene in der Tumorigenese
|
|
US6129911A
(en)
*
|
1998-07-10 |
2000-10-10 |
Rhode Island Hospital, A Lifespan Partner |
Liver stem cell
|
|
US6777388B1
(en)
|
1998-08-21 |
2004-08-17 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
|
CA2877233A1
(en)
|
1999-01-19 |
2000-07-27 |
Lola M. Reid |
Human liver progenitors
|
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
|
US6759393B1
(en)
|
1999-04-12 |
2004-07-06 |
Pfizer Inc. |
Growth hormone and growth hormone releasing hormone compositions
|
|
US8778899B2
(en)
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US6774120B1
(en)
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US7456017B2
(en)
*
|
1999-10-01 |
2008-11-25 |
University Of North Carolina At Chapel Hill |
Processes for clonal growth of hepatic progenitor cells
|
|
US20020187133A1
(en)
*
|
1999-10-01 |
2002-12-12 |
Hiroshi Kubota |
Methods of isolating bipotent hepatic progenitor cells
|
|
US20030108539A1
(en)
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
AU784746B2
(en)
|
1999-11-18 |
2006-06-08 |
Dendreon Corporation |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
US6737270B1
(en)
|
1999-12-07 |
2004-05-18 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Long-term three dimensional tissue culture system
|
|
US20030096411A1
(en)
*
|
1999-12-07 |
2003-05-22 |
George Michalopoulos |
Novel long-term three-dimensional tissue culture system
|
|
ATE391789T1
(de)
|
1999-12-10 |
2008-04-15 |
Invitrogen Corp |
Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
|
|
AU2002219944B2
(en)
|
2000-11-28 |
2008-02-21 |
Medimmune, Llc |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7700341B2
(en)
|
2000-02-03 |
2010-04-20 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
|
US6458589B1
(en)
|
2000-04-27 |
2002-10-01 |
Geron Corporation |
Hepatocyte lineage cells derived from pluripotent stem cells
|
|
US7256042B2
(en)
*
|
2000-04-27 |
2007-08-14 |
Geron Corporation |
Process for making hepatocytes from pluripotent stem cells
|
|
US7473555B2
(en)
|
2000-04-27 |
2009-01-06 |
Geron Corporation |
Protocols for making hepatocytes from embryonic stem cells
|
|
US7282366B2
(en)
*
|
2000-04-27 |
2007-10-16 |
Geron Corporation |
Hepatocytes for therapy and drug screening made from embryonic stem cells
|
|
AU2001268449A1
(en)
|
2000-06-14 |
2001-12-24 |
Vistagen, Inc. |
Toxicity typing using liver stem cells
|
|
EP1294949A4
(de)
|
2000-06-15 |
2004-08-25 |
Human Genome Sciences Inc |
Menschlicher tumornekrosefaktor delta und epsilon
|
|
AU2001268427B2
(en)
|
2000-06-16 |
2007-03-29 |
Glaxosmithkline Intellectual Property Limited |
Antibodies that immunospecifically bind to blys
|
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
EP2065052A3
(de)
|
2000-08-30 |
2009-08-19 |
Pfizer Products Inc. |
Anti-IgE Vakzine
|
|
US20030175255A1
(en)
*
|
2000-10-03 |
2003-09-18 |
Hiroshi Kubota |
Methods of isolating bipotent hepatic progenitor cells
|
|
AU2002213197A1
(en)
*
|
2000-10-12 |
2002-04-22 |
Massachusetts General Hospital |
Plasma supplement and use in liver assist systems
|
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
US7090843B1
(en)
|
2000-11-28 |
2006-08-15 |
Seattle Genetics, Inc. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
EP1355919B1
(de)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Moleküle mit längeren halbwertszeiten, zusammensetzungen und deren verwendung
|
|
US7125703B2
(en)
|
2001-03-13 |
2006-10-24 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US7172892B2
(en)
|
2001-03-22 |
2007-02-06 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
|
JP2005506047A
(ja)
|
2001-03-27 |
2005-03-03 |
デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー |
膜貫通型セリンプロテアーゼ9をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法
|
|
US7029838B2
(en)
|
2001-03-30 |
2006-04-18 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Prevascularized contructs for implantation to provide blood perfusion
|
|
JP2004536579A
(ja)
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
血管内皮増殖因子2
|
|
US7112430B2
(en)
|
2001-05-14 |
2006-09-26 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
JP2003047482A
(ja)
|
2001-05-22 |
2003-02-18 |
Pfizer Prod Inc |
非アナフィラキシー誘発性IgEワクチン
|
|
MXPA03010747A
(es)
|
2001-05-25 |
2004-03-02 |
Human Genome Sciences Inc |
Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
|
|
ATE371018T1
(de)
*
|
2001-06-22 |
2007-09-15 |
Stemcells Inc |
Le-zellen (liver engrafting cells), assays und verwendungen davon
|
|
WO2003002746A2
(en)
|
2001-06-29 |
2003-01-09 |
Novartis Ag |
Perv screening method and use thereof
|
|
CA2453100C
(fr)
|
2001-07-06 |
2013-10-29 |
Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) |
Nouvelles lignees d'hepatomes humains, leurs obtentions et leurs applications
|
|
US7452532B2
(en)
*
|
2001-09-30 |
2008-11-18 |
Scicotec Gmbh |
Transluminal application of adult stem cells for body organ tissue repair
|
|
US20040058309A1
(en)
*
|
2001-10-12 |
2004-03-25 |
Junji Washizu |
Plasma supplement and use in liver assist systems
|
|
EP2270049A3
(de)
|
2002-04-12 |
2011-03-09 |
Medimmune, Inc. |
Rekombinante Anti-Interleukin-9-Antikörper
|
|
AU2003228067B2
(en)
|
2002-04-22 |
2008-05-29 |
Recopharma Ab |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
RU2346981C2
(ru)
*
|
2002-07-19 |
2009-02-20 |
Веста Терапьютикс, Инк. |
Способ получения жизнеспособных клеток печени человека, в том числе печеночных стволовых клеток/клеток-предшественников
|
|
PT1534335E
(pt)
|
2002-08-14 |
2012-02-28 |
Macrogenics Inc |
Anticorpos específicos de fcγriib e processos para a sua utilização
|
|
US20040151729A1
(en)
*
|
2002-10-28 |
2004-08-05 |
George Michalopoulos |
Novel long-term three-dimensional culture system
|
|
US7544499B2
(en)
|
2002-12-16 |
2009-06-09 |
Halozyme, Inc. |
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
|
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
AU2004206250B8
(en)
|
2003-01-21 |
2009-09-17 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof
|
|
WO2004071462A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University |
Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
|
|
AU2004214932B2
(en)
|
2003-02-24 |
2009-12-03 |
Marine Polymer Technologies, Inc. |
Cell-polymer fiber compositions and use thereof
|
|
EP2330213A1
(de)
|
2003-03-05 |
2011-06-08 |
Halozyme, Inc. |
Lösliches Hyaluronidaseglykoprotein (sHASEGP), Verfahren zu dessen Herstellung, Verwendungen und pharmazeutische Zusammensetzunge, die dieses umfassen
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
KR101224235B1
(ko)
|
2003-04-11 |
2013-01-25 |
메디뮨 엘엘씨 |
재조합 il9 항체 및 그의 용도
|
|
CA2532250A1
(en)
|
2003-07-15 |
2005-02-03 |
Barros Research Institute |
Compositions and methods for immunotherapy of cancer and infectious diseases
|
|
EP2128270B1
(de)
|
2003-08-08 |
2012-10-03 |
Genenews Inc. |
Osteoarthritis-Biomarker und Verwendungen davon
|
|
EP1660186B1
(de)
|
2003-08-18 |
2013-12-25 |
MedImmune, LLC |
Humanisierung von antikörpern
|
|
DE602004027538D1
(de)
|
2003-12-01 |
2010-07-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
|
MX361174B
(es)
|
2003-12-23 |
2018-11-29 |
Genentech Inc |
Anticuerpos anti-il13 novedosos y sus usos.
|
|
US10066268B2
(en)
|
2004-05-07 |
2018-09-04 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer
|
|
PT1773978E
(pt)
*
|
2004-05-19 |
2014-05-29 |
Massachusetts Inst Technology |
Modelo de doença com células/tecidos tri-dimensionais perfundidos
|
|
WO2006047639A2
(en)
|
2004-10-27 |
2006-05-04 |
Medimmune, Inc. |
Modulation of antibody specificity by tailoring the affinity to cognate antigens
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
CN103497993A
(zh)
|
2005-02-07 |
2014-01-08 |
基因信息公司 |
轻度骨关节炎生物标志物及其用途
|
|
EP1869192B1
(de)
|
2005-03-18 |
2016-01-20 |
MedImmune, LLC |
Rahmenmischung von antikörpern
|
|
JP5838021B2
(ja)
|
2005-04-15 |
2015-12-24 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディとその使用
|
|
DK2573114T3
(en)
|
2005-08-10 |
2016-07-04 |
Macrogenics Inc |
The identification and production of antibodies with variant Fc regions, and methods of using same
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
US8249814B2
(en)
|
2005-10-21 |
2012-08-21 |
Genenews Inc. |
Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
|
|
DK2500030T4
(en)
|
2005-11-04 |
2018-10-29 |
Genentech Inc |
Use of complement pathway inhibitors for the treatment of eye diseases
|
|
CA2634510C
(en)
|
2005-12-21 |
2018-01-09 |
Universite Catholique De Louvain |
Isolated liver stem cells
|
|
GB0605761D0
(en)
|
2006-03-22 |
2006-05-03 |
Imp Innovations Ltd |
Anti-inflammatory proteins and improved vaccines
|
|
EP2387995A1
(de)
|
2006-03-30 |
2011-11-23 |
PTC Therapeutics, Inc. |
Verfahren zur Produktion von funktionellem Protein aus DNA mit Nonsense-Mutation und Behandlung von damit assoziierten Erkrankungen
|
|
GB2453074B
(en)
*
|
2006-06-02 |
2011-06-22 |
Geron Corp |
Differentiation of primate pluripotent cells to hepatocyte-lineage cells
|
|
EP2029173B1
(de)
|
2006-06-26 |
2016-07-20 |
MacroGenics, Inc. |
Fc-riib-spezifische antikörper und verfahren zu ihrer anwendung
|
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
|
EP2484696B1
(de)
|
2006-08-28 |
2017-08-16 |
Kyowa Hakko Kirin Co., Ltd. |
Antagonistische hLIGHT-spezifische menschliche monoklonale Antikörper
|
|
EP2064335A4
(de)
|
2006-10-16 |
2011-03-30 |
Medimmune Llc |
Moleküle mit reduzierter halbwertzeit, zusammensetzungen und ihre verwendung
|
|
EP2514439A1
(de)
|
2006-11-15 |
2012-10-24 |
Functional Genetics, Inc. |
Anti-TSG101-Antikörper und deren Verwendung bei der Behandlung von Virusinfektionen
|
|
EP2099827B1
(de)
|
2006-12-18 |
2018-11-21 |
Genentech, Inc. |
Antagonistische antikörper gegen notch-3 und ihre verwendung zur prävention und behandlung von notch-3-vermittelten krankheiten
|
|
EP2158221B1
(de)
|
2007-06-21 |
2018-08-29 |
MacroGenics, Inc. |
Kovalente diabodies und deren verwendung
|
|
EP2195023B1
(de)
|
2007-08-29 |
2018-03-07 |
Sanofi |
Humanisierte anti-cxcr5-antikörper, derivate und anwendungsverfahren
|
|
CN106349390B
(zh)
|
2008-04-02 |
2019-12-10 |
宏观基因有限公司 |
Bcr-复合体-特异性抗体和其使用方法
|
|
SG189730A1
(en)
|
2008-04-02 |
2013-05-31 |
Macrogenics Inc |
Her2/neu-specific antibodies and methods of using same
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2010033279A2
(en)
|
2008-06-04 |
2010-03-25 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
|
WO2010027364A1
(en)
|
2008-09-07 |
2010-03-11 |
Glyconex Inc. |
Anti-extended type i glycosphingolipid antibody, derivatives thereof and use
|
|
JP5734201B2
(ja)
|
2008-12-19 |
2015-06-17 |
マクロジェニクス,インコーポレーテッド |
共有結合型ダイアボディ及びその使用
|
|
US20110312872A1
(en)
|
2008-12-22 |
2011-12-22 |
Universität Regensburg |
Norrin in the treatment of diseases associated with an increased tgf-beta activity
|
|
EP2437767B1
(de)
|
2009-06-01 |
2015-07-08 |
MedImmune, LLC |
Moleküle mit verlängerter halbwertzeit und verwendungen dafür
|
|
MX2012001882A
(es)
|
2009-08-13 |
2012-04-11 |
Crucell Holland Bv |
Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso.
|
|
WO2011035205A2
(en)
|
2009-09-18 |
2011-03-24 |
Calmune Corporation |
Antibodies against candida, collections thereof and methods of use
|
|
WO2011073521A1
(en)
|
2009-12-15 |
2011-06-23 |
Petri Salven |
Methods for enriching adult-derived endothelial progenitor cells and uses thereof
|
|
EP2926821B1
(de)
|
2010-03-05 |
2019-12-25 |
Tissue Genesis, LLC |
Zusammensetzungen zur unterstützung von gewebeintegration und inokulation von transplantiertem gewebe und transplantiertem gezüchtetem penisgewebe mit stromazellen aus fettgewebe
|
|
EP2591000B1
(de)
|
2010-07-09 |
2017-05-17 |
Janssen Vaccines & Prevention B.V. |
Antikörper gegen humanes respiratorisches syncytialvirus (rsv) und ihre verwendung
|
|
US9458509B2
(en)
|
2010-07-22 |
2016-10-04 |
President And Fellows Of Harvard College |
Multiple input biologic classifier circuits for cells
|
|
ES2667100T3
(es)
|
2010-08-02 |
2018-05-09 |
Macrogenics, Inc. |
Diacuerpos covalentes y sus usos
|
|
WO2012027711A2
(en)
|
2010-08-26 |
2012-03-01 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for treating bone defects
|
|
EP2627346B1
(de)
|
2010-10-14 |
2016-03-23 |
Xigen Inflammation Ltd. |
Zelldurchlässiger peptidhemmer des jnk-signaltransduktionsweges zur verwendung in der behandlung von uveitis
|
|
AU2010362444B2
(en)
|
2010-10-14 |
2015-08-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
EP2799078A1
(de)
|
2010-11-12 |
2014-11-05 |
Allergan, Inc. |
Verstoffwechseltes konditioniertes Wachstumsmedium und Verwendungsverfahren dafür
|
|
US9376495B2
(en)
|
2011-05-21 |
2016-06-28 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use in extending serum half-life
|
|
CN110777124A
(zh)
|
2011-10-27 |
2020-02-11 |
威尔斯达眼科制剂公司 |
编码视杆细胞来源的视锥细胞活力因子的载体
|
|
WO2013079213A1
(en)
|
2011-11-30 |
2013-06-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
|
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
|
JP6411218B2
(ja)
|
2012-02-15 |
2018-10-24 |
ノヴォ ノルディスク アー/エス |
骨髄細胞で発現されるトリガー受容体1(trem−1)に結合し、それを遮断する抗体
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
|
WO2013155439A1
(en)
|
2012-04-13 |
2013-10-17 |
Massachusetts Institute Of Technology |
Analog and mixed-signal computation and circuits in living cells
|
|
AU2013251649B2
(en)
|
2012-04-24 |
2019-04-04 |
Vcell Therapeutics, Inc. |
Generating pluripotent cells de novo
|
|
WO2014006063A2
(en)
|
2012-07-02 |
2014-01-09 |
Medizinische Universität Wien |
Complement split product c4d for the treatment of inflammatory conditions
|
|
MX2015006491A
(es)
|
2012-11-23 |
2015-12-03 |
Seres Health Inc |
Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
|
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
|
MX369877B
(es)
|
2013-02-04 |
2019-11-25 |
Seres Therapeutics Inc |
Composiciones y metodos.
|
|
JP2016519664A
(ja)
|
2013-03-15 |
2016-07-07 |
セレス セラピューティクス インコーポレイテッド |
ネットワークを基にした微生物組成物及び方法
|
|
WO2014186394A1
(en)
|
2013-05-13 |
2014-11-20 |
Oregon Health & Science University |
Human pluripotent stem cells produced by somatic cell nuclear transfer
|
|
US11085067B2
(en)
|
2013-06-10 |
2021-08-10 |
President And Fellows Of Harvard College |
Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
|
|
KR102181336B1
(ko)
|
2013-06-13 |
2020-11-24 |
오르제네시스 엘티디. |
세포 집단, 이의 전환분화 방법 및 이용 방법
|
|
WO2015197098A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
JP6474394B2
(ja)
|
2013-07-05 |
2019-02-27 |
ユニベルシテ カトリック ドゥ ルーベン |
ヒト成体肝臓幹細胞由来の馴化培地および肝臓障害の治療におけるその使用
|
|
AU2014331971B2
(en)
|
2013-10-08 |
2018-07-19 |
Vivorte, Inc. |
Processed bone particle compositions and related methods
|
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
|
EP3450571B1
(de)
|
2014-02-24 |
2023-04-05 |
Celgene Corporation |
Verfahren zur verwendung eines aktivators von cereblon für neuronale zellexpansion und behandlung von erkrankungen des zentralnervensystems
|
|
JP2017513517A
(ja)
|
2014-03-19 |
2017-06-01 |
ブイセル セラピューティックス,インコーポレイテッド |
多能性細胞に関連する方法
|
|
JP6832709B2
(ja)
|
2014-05-16 |
2021-02-24 |
メディミューン,エルエルシー |
新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
|
|
EP3146065B1
(de)
|
2014-05-19 |
2024-11-13 |
Memorial Sloan Kettering Cancer Center |
Verfahren und zusammensetzungen zur verringerung von clostridium-difficile-infektionen
|
|
CN106536559B
(zh)
|
2014-07-17 |
2021-04-27 |
诺和诺德股份有限公司 |
定点诱变trem-1抗体以降低黏度
|
|
EP3204031A2
(de)
|
2014-10-08 |
2017-08-16 |
Xigen Inflammation Ltd. |
Verwendung von zelldurchlässigen peptidhemmern des jnk-signaltransduktionsweges zur behandlung verschiedener krankheiten
|
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
|
US10729790B2
(en)
|
2015-05-26 |
2020-08-04 |
Salk Institute For Biological Studies |
Motor neuron-specific expression vectors
|
|
US10966414B2
(en)
|
2015-05-26 |
2021-04-06 |
California Institute Of Technology |
Population control using engineered translocations
|
|
EP3379935A4
(de)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
Verfahren und zusammensetzungen zur reduktion vancomycin-resistenten enterokokken
|
|
US20190145961A1
(en)
|
2016-04-20 |
2019-05-16 |
Washington University |
Ppar agonist or lxr agonist for use in the treatment of systemic lupus erythematosus by modulation of lap activity
|
|
WO2018005477A1
(en)
|
2016-06-27 |
2018-01-04 |
University Of Louisville Research Foundation, Inc. |
Spheroids including biologically-relevant materials and related methods
|
|
WO2018106652A1
(en)
|
2016-12-06 |
2018-06-14 |
The Regents Of The University Of Michigan |
Bioengineered vascular network
|
|
MX2019010286A
(es)
|
2017-04-20 |
2019-10-21 |
Univ Oregon Health & Science |
Correccion de genes humanos.
|
|
WO2018207179A1
(en)
|
2017-05-08 |
2018-11-15 |
Orgenesis Ltd. |
Transdifferentiated cell populations and methods of use thereof
|
|
BR112020002992A2
(pt)
|
2017-08-14 |
2020-08-18 |
Seres Therapeutics, Inc. |
composições e métodos para tratamento de doença colestática
|
|
JP2021501185A
(ja)
|
2017-10-30 |
2021-01-14 |
セレス セラピューティクス インコーポレイテッド |
抗生物質耐性を処置するための組成物及び方法
|
|
CR20250022A
(es)
|
2018-04-02 |
2025-02-25 |
Bristol Myers Squibb Co |
Anticuerpos anti-trem-1, ácidos nucleicos y vectores de los mismos (divisional 2020-0450)
|
|
US20210238312A1
(en)
|
2018-06-13 |
2021-08-05 |
The Children's Medical Center Corporation |
Methods and compositions relating to high-throughput models for antibody discovery and/or optimization
|
|
US11965172B2
(en)
|
2018-11-05 |
2024-04-23 |
California Institute Of Technology |
DNA sequence modification-based gene drive
|
|
CA3142113A1
(en)
|
2019-05-28 |
2020-12-03 |
Xiling Shen |
Methods and apparatuses for patient-derived micro-organospheres
|
|
GB201914296D0
(en)
|
2019-10-03 |
2019-11-20 |
Univ Oxford Innovation Ltd |
Treatment
|
|
US20250325469A1
(en)
|
2021-01-24 |
2025-10-23 |
Michael David FORREST |
Inhibitors of atp synthase - cosmetic and therapeutic uses
|
|
UY40097A
(es)
|
2022-01-07 |
2023-07-14 |
Johnson & Johnson Entpr Innovation Inc |
Materiales y métodos de proteínas de unión a il-1b
|
|
WO2024013727A1
(en)
|
2022-07-15 |
2024-01-18 |
Janssen Biotech, Inc. |
Material and methods for improved bioengineered pairing of antigen-binding variable regions
|
|
CN121285568A
(zh)
|
2023-03-30 |
2026-01-06 |
制药五有限责任公司 |
编码视杆细胞源性视锥细胞活力因子和人IgK信号序列的载体
|
|
WO2026072752A1
(en)
|
2024-09-27 |
2026-04-02 |
Pharma Cinq, Llc |
Rod-derived cone viability factor fusion protein
|